Skip to main content
. 2020 Aug 6;70(2):365–376. doi: 10.1007/s00262-020-02679-5

Fig. 5.

Fig. 5

IBI322 selectively binds to dual antigen-expressing tumor cell PET/CT imaging in tumor-bearing mice. a, b Compared to anti-CD47, IBI322 showed significantly higher tumor uptake and lower heart, liver, and spleen uptake. Tumor and spleen are indicated by white pink circles, respectively. c Time course quantification of tumor uptake treatment with IBI322, anti-PD-L1, and anti-CD47